Australia markets open in 7 hours 31 minutes

Zydus Lifesciences Limited (ZYDUSLIFE.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
1,205.80+26.35 (+2.23%)
At close: 03:30PM IST

Zydus Lifesciences Limited

Zydus Corporate Park
Scheme No. 63 Survey No. 536, Khoraj (Gandhinagar) Near Vaishnodevi Circle, Sarkhej Gandhinagar Highw
Ahmedabad 382481
India
91 79 4804 0000
https://zyduslife.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full-time employees26,921

Key executives

NameTitlePayExercisedYear born
Dr. Sharvil Pankajbhai PatelMD & Executive Director300MN/A1979
Dr. Ganesh Narayan NayakCOO & Executive Director140MN/A1955
Mr. Punit PatelPresident & CEO of AmericaN/AN/AN/A
Mr. Nitinkumar Dalsukhray ParekhChief Financial Officer54.31MN/AN/A
Mr. Arvind BothraHead of Investor RelationsN/AN/AN/A
Mr. Dhaval Narendra SoniCompany Secretary & Compliance Officer2.09MN/AN/A
Amounts are as of 31 December 2024, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally. It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases. The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands. In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses. Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities. The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022. Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.

Corporate governance

Zydus Lifesciences Limited’s ISS governance QualityScore as of 1 July 2024 is 5. The pillar scores are Audit: 8; Board: 4; Shareholder rights: 9; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.